Cannabis, Pain & the Opioid Crisis

Course Curriculum

This self-paced course will discuss key concepts surrounding the safety and efficacy of cannabis for pain mitigation, and explore the emerging data demonstrating that cannabinoids may potentially act as either an effective adjunctive treatment or as a substitute for opioid-based medications. It will then provide an overview of the clinical data assessing the substance’s analgesic properties, and also examine prescription drug use trends among chronic pain patients treated with medical cannabis. More limited data assessing the potential role cannabinoids may play in reducing certain drug cravings will be considered, and their possible role in treatment outcomes among those with an opioid dependency will also be discussed.

About Our Self-Paced Electives

Self-Paced Programs are asynchronous, meaning you may log on and complete the courses anytime, anywhere that is convenient for you. You can access the course online as soon as you enroll.

Programs consist of reading materials developed by our expert faculty, accompanied by videos, texts, and recommended resources.

All self-paced programs include live links to a wealth of information that allow you to dig deeper into subjects of particular interest.

Each program also includes a Virtual Video and Resource Library with corresponding recorded lectures from our faculty.

Self-paced students receive access to virtual field trips, grow labs, the Oaksterdam Alumni Network, and more.

Completion of all requirements results in OU certification.

Cannabis, Pain & the Opioid Crisis

FREE

This free, self-paced course has been designed to provide you with trusted curated information as a platform to do further research on the relationship between cannabis and prescription pain killers. Students have 180 days to complete this course.

SPEAK TO AN ADVISOR

Related Courses

Not Interested in the Full Course? Try Our À la Carte Classes!

Get the Latest News from Oaksterdam

Get the Latest and Greatest News On the Cannabis Industry in Our Newsletter